Persistent Asset Partners »

Evolus shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $9 318 0.03

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Evolus

Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Frazier Life Sciences Management
Vanguard Capital Management
Soleus Capital Management
Stonepine Capital Management
State Street Corporation
Millennium Management
Armistice Capital
Geode Capital Management
Perceptive Advisors
Rice Hall James & Associates
Gail Mannix

View all funds holding Evolus